FDA Inspection 1153285 — Vitalant
The FDA completed an inspection of Vitalant on Sep 8, 2021 in Memphis, TN. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 8, 2021
- Fiscal Year
- 2021
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Memphis, TN (United States)